5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine, 95.0%, 1g

3-Bromo-6-oxo-1,6-dihydropyridine-2-carbonitrile, 95.0%, 1g

Butanedioic acid, compd. with 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide (1:1), 98%, 5g

(4S,4'S)-2,2'-(Cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 250mg

N-(3,4-Dimethylbenzyl)ethanamine, 95.0%, 5g

Methyl 5-(3-fluorophenyl)isoxazole-3-carboxylate, 5g

N-(3-Dimethylaminopropyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 95.0%, 100mg

4-Amino-3-nitrobenzenesulfonamide, 95.0%, 2.5g

5-Bromobenzo[d]isoxazol-3-ylamine, 95.0%, 5g

1-TERT-BUTYL 2-METHYL 5-CYANOPYRROLIDINE-1,2-DICARBOXYLATE, 95.0%, 100mg

7-oxo-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic acid, 95.0%, 5g

METHYL 3-CYCLOPROPYL-3-(3-HYDROXYPHENYL)PROPANOATE, 95.0%, 5g

2,4-Dimethylquinoline-3-carboxylic acid, 95+%, 1g